NICE Ltd.NICENASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank51
3Y CAGR-54.0%
5Y CAGR+2.1%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-54.0%/yr
vs +42.0%/yr prior
5Y CAGR
+2.1%/yr
Recent deceleration
Acceleration
-96.0pp
Decelerating
Percentile
P51
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
3 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 1.36% |
| Q3 2025 | 0.78% |
| Q2 2025 | 0.74% |
| Q1 2025 | -5.96% |
| Q4 2024 | 3.56% |
| Q3 2024 | 5.75% |
| Q2 2024 | -1.49% |
| Q1 2024 | 8.28% |
| Q4 2023 | -4.39% |
| Q3 2023 | 7.89% |
| Q2 2023 | 0.69% |
| Q1 2023 | -7.44% |
| Q4 2022 | 13.95% |
| Q3 2022 | 0.77% |
| Q2 2022 | -4.04% |
| Q1 2022 | -1.13% |
| Q4 2021 | 3.98% |
| Q3 2021 | 19.71% |
| Q2 2021 | 5.18% |
| Q1 2021 | 5.33% |
| Q4 2020 | 1.23% |
| Q3 2020 | 3.21% |
| Q2 2020 | 1.85% |
| Q1 2020 | 1.18% |
| Q4 2019 | 7.49% |
| Q3 2019 | 4.47% |
| Q2 2019 | -0.24% |
| Q1 2019 | -0.51% |
| Q4 2018 | -1.87% |
| Q3 2018 | 9.77% |
| Q2 2018 | -5.26% |
| Q1 2018 | -8.51% |
| Q4 2017 | 11.07% |
| Q3 2017 | 5.24% |
| Q2 2017 | -0.16% |
| Q1 2017 | 5.07% |
| Q4 2016 | 21.65% |
| Q3 2016 | -2.64% |
| Q2 2016 | 6.14% |
| Q1 2016 | -8.56% |